Atlas Trials

Optimization for Regorafenib in HCC

Clinical trial NCT04476329 · TERMINATED

Trial details

NCT number
NCT04476329
Sponsor
SC Liver Research Consortium, LLC
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2021-01-21
Primary completion
2021-10-13
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.